Pijn bij Kwetsbare Ouderen - NVAM

terug naar de inhoudsopgave– McKellar G, Madhok R, Singh G. Update on the use of analgesics versusnonsteroidal anti-inflammatory drugs in rheumatic disorders: Risks andbenefits. Curr Opin Rheumatol 2008;20:239–245.– Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitive systematicreview of topically applied non-steroidal anti-inflammatory drugs. BMJ1998;316: 333–338.– Moore RA, Derry S, Makinson GT, McQuay HJ. Tolerability and adverse eventsin clinical trials of celecoxib in osteoartrose and rheumatoid artrose: Systematicreview and meta-analysis of information from company clinical trial reports.Artrose Res Ther 2005;7:R644–R665.– Moore RA, Derry S, Phillips CJ, McQuay HJ. Nonsteroidal anti-inflammatorydrugs (NSAID’s ), cyxlooxygenase-2 selective inhibitors (COX-2-selectieves)and gastrointestinal harm: Review of clinical trials and clinical practice. BMCMusculoskelet Disord 2006;7:79.– Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, Coderre T,Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, SquireP, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M, Mailis-Gagnon A, Panju A, Rollman GB, Velly A; Canadian Pain Society. Pharmacologicalmanagement of chronic neuropathic pain. Consensus statement andguidelines from the Canadian Pain Society. Pain Res Manage 2007;12:13–21.– Nederlands Huisartsgenootschap (NHG). NHG-standpunt Maximale doseringparacetamol, 2004.– Nederlands Huisartsgenootschap (NHG). FTR pijnbestrijding (2007)– Nederlands Huisartsgenootschap (NHG). NHG-Standaard Artritis, 2010.– Niccoli L, Bellino S, Cantini F. Renal tolerability of three commonly employednon-steroidal anti-inflammatory drugs in elderly patiënts with osteoartrose.Clin Exp Rheumatol 2002;20:201–207.– National Institute for Health and Clinical Excellence(NICE). ‘Neuropathic pain:The pharmacological management of neuropathic pain in adults in non-specialistsettings’ (2010)– Nicholson B, Passik SD. Management of chronic noncancer pain in the primarycare setting. South Med J 2007;100:1028–1036.– Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioïd therapy forchronic noncancer pain: A systematic review and meta-analysis of efficacy andsafety. J Pain Symptom Manage 2008;35:214–228.– Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, SchoellesKM. Long-term opioid management for chronic noncancer pain. CochraneDatabase Syst Rev. 2010 Jan 0;(1):CD006605.– O'Connor AB, Dworkin RH.Treatment of neuropathic pain: an overview ofrecent guidelines. Am J Med. 2009 Oct;122(10 Suppl):S22-32. Review.– Ofman JJ, Maclean CH, Straus WL, Morton SC, Berger ML, Roth EA, ShekellePG. Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.Artrose Rheum 2003;49: 508–518.– van Ojik AL,. Jansen PAF, Brouwers JRBJ, van Roon EN. Opioïden, Geneesmiddelbeoordelingvoor de kwetsbare oude patiënt in het FarmacotherapeutischKompas. Ephor 2011.– Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, LangfordR, Likar R, Raffa RB, Sacerdote P. CONSENSUS STATEMENT Opioïds andthe Management of Chronic Severe Pain in the Elderly: Consensus Statementof an International Expert Panel with Focus on the Six Clinically Most OftenUsed World Health Organization step III Opioïds (Buprenorfine, Fentanyl,Hydromorphone, Methadone, Morphine, Oxycodone). Pain Pract 2008;8:287-313.– Portenoy RK. Adjuvant analgesics in pain management. In: Doyle D, HanksGW, MacDonald N, eds. Oxford Textbook of Palliative Medicine, 2nd Ed. NewYork: Oxford University Press, 1998, pp 361–390.– Prescott LF, Speirs GC, Critchley JA, Temple RM, Winney RJ. Paracetamoldisposition and metabolite kinetics in patiënts with chronic renal failure. Eur JClin Pharmacol. 1989;36(3):291-7.multidisciplinaire Richtlijn pijn bij kwetsbare ouderen130